Directory
>
Katherine Stueland
Katherine Stueland
Account Supervisor | GeneDx
New York, New York, United States
Katherine Stueland
Summary
Katherine Stueland is a seasoned executive in the biotechnology and healthcare sectors, currently serving as the CEO of GeneDx. With a strong background in drug discovery and investor relations, she has successfully led transformational initiatives that have significantly increased patient access to genomic testing. Katherine's leadership has been pivotal in securing FDA approvals for groundbreaking therapies, including the first cancer immunotherapy. Her strategic vision and expertise in communications and public relations have driven substantial revenue growth and enhanced stakeholder engagement. An advocate for mental health, she actively contributes to organizations focused on youth emotional well-being. Katherine graduated with a degree in Science and English Literature from Miami University and has been recognized as one of the most influential leaders in biotech. Her commitment to leveraging genomic insights to improve healthcare outcomes sets her apart in the industry.
Katherine Stueland
Work Experience
Chief Executive Officer at
GeneDx
June 2021 - Present
Frequently Asked Questions about Katherine Stueland
What is Katherine Stueland email address?
Katherine Stueland's primary email address is *********@genedx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Katherine Stueland work for?
Katherine Stueland is a Account Supervisor at GeneDx.
How can I directly contact Katherine Stueland?
To contact Katherine Stueland directly, you can use the email address *********@genedx.com. Complete contact information is available upon registration with Muraena.
Who is Katherine Stueland?
Katherine Stueland is a seasoned executive in the biotechnology and healthcare sectors, currently serving as the CEO of GeneDx. With a strong background in drug discovery and investor relations, she has successfully led transformational initiatives that have significantly increased patient access to genomic testing. Katherine's leadership has been pivotal in securing FDA approvals for groundbreaking therapies, including the first cancer immunotherapy. Her strategic vision and expertise in communications and public relations have driven substantial revenue growth and enhanced stakeholder engagement. An advocate for mental health, she actively contributes to organizations focused on youth emotional well-being. Katherine graduated with a degree in Science and English Literature from Miami University and has been recognized as one of the most influential leaders in biotech. Her commitment to leveraging genomic insights to improve healthcare outcomes sets her apart in the industry.
Katherine`s contact details
*********@genedx.com
*********@dendreon.com
******************@invitae.com
******************@sema4.com
Colleagues
PR Intern
Principal, Analytical Services
Founder
Associate
Field Managed Care Specialist, AstraZeneca
Audit Intern
Planner/Buyer
Teaching Assistant
Research Scientist